SCHEMBL2549032

SCHEMBL2549032

Cc1[nH]ccc1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11726611 0.83 KMT2A (0.35)
SCHEMBL16043412 0.79
SCHEMBL11870617 0.77 KDM4E (0.39)
SCHEMBL4733414 0.76
SCHEMBL5227532 0.76 NAPRT (0.53)
SCHEMBL4117555 0.76 MAPT (0.46)
Biphenyl SCHEMBL27447835 0.76 MAPT (0.47)
SCHEMBL69690 0.75 KEAP1 (0.47)
SCHEMBL28659187 0.74 LMNA (0.41)
SCHEMBL6825281 0.74 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008031888-A2 CONDENSED PYRIMIDINONES ACTIVE ON GLUTAMATERGIC RECEPTORS CAMPIANI GIUSEPPE (IT) 2008-03-20 WO claimed
US-12408914-B2 Systems and methods for customizing mechanical strength in stimuli-responsive bioabsorbable materials CILAG GMBH INTERNATIONAL (CH) 2025-09-09 US disclosed
US-12404279-B2 Deubiquitinase inhibitors and methods of use thereof MOLECURE S.A. (PL) 2025-09-02 US disclosed
EP-4543502-A1 SYSTEMS AND METHODS FOR CUSTOMIZING MECHANICAL STRENGTH IN STIMULI-RESPONSIVE BIOABSORBABLE MATERIALS Cilag GmbH International (CH) 2025-04-30 EP disclosed
WO-2024261659-A1 SYSTEMS AND METHODS FOR CUSTOMIZING MECHANICAL STRENGTH IN STIMULI-RESPONSIVE BIOABSORBABLE MATERIALS CILAG GMBH INTERNATIONAL (CH) 2024-12-26 WO disclosed
US-20240423620-A1 COMPRESSIBLE SURGICAL ADJUNCTS, CARTRIDGES, AND CARTRIDGE ASSEMBLIES AND METHODS OF MAKING SURGICAL ADJUNCTS CILAG GMBH INTERNATIONAL (CH) 2024-12-26 US disclosed
US-20240423617-A1 SYSTEMS AND METHODS FOR CUSTOMIZING MECHANICAL STRENGTH IN STIMULI-RESPONSIVE BIOABSORBABLE MATERIALS CILAG GMBH INTERNATIONAL (CH) 2024-12-26 US disclosed
US-20240382613-A1 METHODS AND SYSTEMS FOR ULTRASOUND STIMULATED STRUCTURES AND DELIVERY OF THERAPEUTIC SPECIES THE PENN STATE RESEARCH FOUNDATION 2024-11-21 US disclosed
EP-4452984-A1 DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF Molecure S.A. (PL) 2024-10-30 EP disclosed
EP-4447944-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF THERAPEUTIC AND/OR DIAGNOSTIC SPECIES THE PENN STATE RESEARCH FOUNDATION (US) 2024-10-23 EP disclosed
CN-1366524-A Sulfonamide Derivatives as Matrix Metalloproteinase Inhibitors SAMSUNG ELECTRONICS CO LTD (KR) 2002-08-28 CN disclosed
EP-1071427-A1 INTERMITTENT CLAUDICATION THERAPEUTIC DRUGS COMPRISING PYRROLOAZEPINES SUNTORY LIMITED (JP) 2001-01-31 EP disclosed
WO-2000048602-A1 INTERMITTENT CLAUDICATION THERAPEUTIC DRUGS COMPRISING PYRROLOAZEPINES SUNTORY LIMITED (JP) 2000-08-24 WO disclosed
US-4588817-A Antibiotic nodusmicins THE UPJOHN COMPANY (US) 1986-05-13 US disclosed
US-4461903-A Antibiotic nodusmicin derivatives THE UPJOHN COMPANY (US) 1984-07-24 US disclosed
US-4448970-A ANTIBIOTICS, BACTERICIDES THE UPJOHN COMPANY (US) 1984-05-15 US disclosed
US-4363922-A Esters of antibiotic nodusmicin THE UPJOHN COMPANY (US) 1982-12-14 US disclosed
US-4360683-A Antibiotic nodusmicin derivatives THE UPJOHN COMPANY (US) 1982-11-23 US disclosed
US-4351769-A Antibiotic composition of matter THE UPJOHN COMPANY (US) 1982-09-28 US disclosed
US-3966739-A ADRENOLYTIC, HYPOTENSIVE, SEDATIVE, ANTISEROTONINIC SOCIETA' FARMACEUTICI ITALIA S.P.A. (IT) 1976-06-29 US disclosed